Majors, Organizational Legitimacy and Rents from Blockbuster Innovation in the Biopharma Industry Majors, Organizational Legitimacy and Rents from Blockbuster Innovation in the Biopharma Industry adminpmls20162021-03-05T04:00:40-05:00 Learn More
Using tears for precision diagnostics and the development of a potential new therapy for age-related macular degeneration Using tears for precision diagnostics and the development of a potential new therapy for age-related macular degeneration adminpmls20162021-03-05T04:01:14-05:00 Learn More
The dal-GenE trial: A case study of precision medicine in the cardiovascular setting The dal-GenE trial: A case study of precision medicine in the cardiovascular setting adminpmls20162021-03-05T04:01:53-05:00 Learn More
Using Zebrafish to Advance Disease Research Using Zebrafish to Advance Disease Research adminpmls20162021-03-05T04:02:15-05:00 Learn More
Pioneering precision medicine in rheumatoid arthritis Pioneering precision medicine in rheumatoid arthritis adminpmls20162021-03-05T04:02:38-05:00 Learn More
Companion Diagnostics, Precision Medicine and Immuno-Oncology Therapies Companion Diagnostics, Precision Medicine and Immuno-Oncology Therapies adminpmls20162021-03-05T04:03:10-05:00 Learn More
Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities Leveraging Real-World Data for COVID-19 Research: Challenges and Opportunities adminpmls20162021-03-05T04:03:40-05:00 Learn More
COVID‑19 and pharmacogenomics: an association that warrants comprehensive assessment COVID‑19 and pharmacogenomics: an association that warrants comprehensive assessment adminpmls20162021-03-05T04:04:45-05:00 Learn More
Lessons from oncology drive precision medicine across clinical specialties Lessons from oncology drive precision medicine across clinical specialties adminpmls20162021-03-05T04:05:06-05:00 Learn More
A New Playbook for Cure-Seeking Nonprofits A New Playbook for Cure-Seeking Nonprofits adminpmls20162021-03-05T04:05:33-05:00 Learn More
Personalization and standardization: Can we have it all? Personalization and standardization: Can we have it all? adminpmls20162021-03-05T04:05:59-05:00 Learn More